Eltrombopag/Uni-Pharma

Eltrombopag is a medication used to stimulate platelet production in the bone marrow. It is commonly prescribed for conditions affecting platelet counts, such as chronic immune thrombocytopenia. Eltrombopag is an oral medication manufactured by Uni-Pharma.

Eltrombopag is primarily used to increase platelet counts in individuals with certain blood disorders. It works by stimulating the production of megakaryocytes, the cells responsible for creating platelets. This medication is often prescribed for conditions like chronic immune thrombocytopenia, where the body does not produce enough platelets. Eltrombopag may also be used in other situations where low platelet counts are a concern.

Common effects of Eltrombopag may include an increase in platelet counts, which can help reduce the risk of bleeding. Some individuals may experience side effects such as nausea, fatigue, or changes in liver function. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Eltrombopag should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring of liver function may be recommended during treatment. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Eltrombopag may interact with certain medications, including those that affect liver enzymes. It is important to avoid taking Eltrombopag with other drugs that can cause liver toxicity. Additionally, consuming alcohol while taking Eltrombopag may increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.